TotalMarketCap

Cytokinetics

CYTKNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.742 B

$55.58 -12.61%

Close of 6 Nov 2026

As of 6 Nov 2026, Cytokinetics (CYTK) has a market capitalization of $7.74B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$88.0M

#2527 by revenue

Earnings

-$785.0M

Loss-making

Shares outstanding

139,303,351

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #37Arrowhead PharmaceuticalsARWR$8.11B
  2. #38Corcept TherapeuticsCORT$7.86B
  3. #39CytokineticsCYTK$7.74B
  4. #40AlkermesALKS$7.50B
  5. #41AbivaxABVX$7.35B

What if Cytokinetics were worth as much as…

Open the what-if tool →

Gold $28.2T

$202,700.61

Per share 3,647× higher

Bitcoin $1.53T

$10,967.78

Per share 197× higher

Apple $5.02T

$36,006.19

Per share 648× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Cytokinetics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.